NasdaqGM - Delayed Quote USD

ProShares UltraPro Nasdaq Biotechnology (UBIO)

17.77 0.00 (0.00%)
At close: March 27 at 3:59 PM EDT
Loading Chart for UBIO
DELL
  • Previous Close 17.77
  • Open 17.97
  • Bid --
  • Ask --
  • Day's Range 17.43 - 19.24
  • 52 Week Range 13.13 - 32.09
  • Volume 34,710
  • Avg. Volume 0
  • Net Assets 15.09M
  • NAV 17.77
  • PE Ratio (TTM) --
  • Yield 0.00%
  • YTD Daily Total Return -45.70%
  • Beta (5Y Monthly) 3.15
  • Expense Ratio (net) 0.95%

The investment seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the NASDAQ Biotechnology Index® (the "index"). The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

ProShares

Fund Family

Trading--Leveraged Equity

Fund Category

15.09M

Net Assets

2015-06-22

Inception Date

Performance Overview: UBIO

Trailing returns as of 4/2/2020. Category is Trading--Leveraged Equity.

YTD Return

UBIO
45.70%
Category
--
 

1-Year Return

UBIO
40.99%
Category
--
 

3-Year Return

UBIO
13.75%
Category
--
 

Holdings: UBIO

Top 10 Holdings (241.96% of Total Assets)

SymbolCompany% Assets
75.41%
52.94%
38.60%
31.75%
11.72%
GILD
Gilead Sciences, Inc. 7.77%
VRTX
Vertex Pharmaceuticals Incorporated 6.52%
AMGN
Amgen Inc. 6.41%
BIIB
Biogen Inc. 6.30%
REGN
Regeneron Pharmaceuticals, Inc. 4.54%

Sector Weightings

SectorUBIO
Healthcare   99.96%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Related ETF News

Related Tickers